1. Home
  2. RLAY vs ARCB Comparison

RLAY vs ARCB Comparison

Compare RLAY & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$18.33

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$130.52

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
ARCB
Founded
2015
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
RLAY
ARCB
Price
$18.33
$130.52
Analyst Decision
Strong Buy
Buy
Analyst Count
13
14
Target Price
$27.58
★ $166.85
AVG Volume (30 Days)
★ 2.5M
152.8K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 0.37%
EPS Growth
★ 31.78
N/A
EPS
N/A
★ N/A
Revenue
$15,355,000.00
★ $1,657,864,000.00
Revenue This Year
N/A
$12.44
Revenue Next Year
$60.51
$7.93
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 53.44
12.56
52 Week Low
$5.95
$59.43
52 Week High
$21.27
$176.69

Technical Indicators

Market Signals
Indicator
RLAY
ARCB
Relative Strength Index (RSI) 51.84 48.53
Support Level $17.67 $124.99
Resistance Level $20.09 $135.48
Average True Range (ATR) 0.97 3.69
MACD 0.10 0.40
Stochastic Oscillator 65.28 49.94

Price Performance

Historical Comparison
RLAY
ARCB

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: